Ask AI
ProCE Banner Activity

DTR-P. aeruginosa: Pathways to Overcoming Diverse Resistance Profiles 

Podcast Episodes

Join Ryan K. Shields, PharmD, MS, in the second of 3 recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. This episode covers strategies for overcoming diverse antibiotic resistance profiles in DTR-P. aeruginosa.

Released: November 25, 2025

Share

Provided by

Provided by Clinical Care Options, LLC, in partnership with ProCE, LLC

ProCE Banner

Supporters

Supported by an educational grant from Shionogi Pharma, Inc.

Shionogi Pharma, Inc.

Partners

ProCE, LLC

ProCE Banner

Target Audience

This activity is intended for pulmonology, critical care, and infectious disease specialists, including physicians and clinical pharmacists, who care for critically ill patients with carbapenem-resistant gram-negative infections.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Optimize antimicrobial regimens for complex infections involving Pseudomonas aeruginosa with difficult-to-treat resistance

Disclosure

Primary Author

Ryan K. Shields, PharmD, MS: consultant/advisor/speaker: AbbVie, Melinta, Merck, Shionogi; researcher: AbbVie, Innoviva, Melinta, Merck, Roche, Shionogi.